Atlas Trials

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Clinical trial NCT00561522 · UNKNOWN

Trial details

NCT number
NCT00561522
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatocellular CarcinomaNeoplasm Metastasis
Start date
2007-11-01
Primary completion
2012-07-01
Enrollment
290

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.